Campbell & CO Investment Adviser LLC Madrigal Pharmaceuticals, Inc. Transaction History

Campbell & CO Investment Adviser LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$146.04 - $225.78 $959,628 - $1.48 Million	6,571 New	6,571 $959,000
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $83,964 - $426,424	1,438 New	1,438 $417,000
Q2 2022 Aug 09, 2022	SELL	$58.04 - $100.2 $765,895 - $1.32 Million	-13,196 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$55.89 - $101.89 $737,524 - $1.34 Million	13,196 New	13,196 $1.3 Million
Q4 2021 Feb 10, 2022	SELL	$72.34 - $95.09 $361,700 - $475,450	-5,000 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$78.35 - $105.02 $391,750 - $525,100	5,000 New	5,000 $399,000

298

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.9B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.